These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Some novel piperidine analogues having strong alpha glucosidase inhibition. Rafiq K; Saify ZS; Nesar S; Faiyaz A; Muhammad IN Pak J Pharm Sci; 2018 Jul; 31(4):1185-1189. PubMed ID: 30033400 [TBL] [Abstract][Full Text] [Related]
4. Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase. Özil M; Emirik M; Beldüz A; Ülker S Bioorg Med Chem; 2016 Nov; 24(21):5103-5114. PubMed ID: 27576293 [TBL] [Abstract][Full Text] [Related]
5. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors. Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors. Wang G; Peng Z; Gong Z; Li Y Bioorg Chem; 2018 Aug; 78():195-200. PubMed ID: 29587132 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives. Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors. Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton. Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors. Wang G; Peng Z; Wang J; Li J; Li X Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916 [TBL] [Abstract][Full Text] [Related]
11. Organocatalyzed Novel Synthetic Methodology for Highly Functionalized Piperidines as Potent α-Glucosidase Inhibitors. Farooq A; Shahazadi L; Bajda M; Ullah N; Rauf A; Shahzad SA; Khan AF; Ashraf M; Yar M Arch Pharm (Weinheim); 2016 Sep; 349(9):724-32. PubMed ID: 27489132 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors. Wang G; Peng Z; Wang J; Li X; Li J Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular docking and α-glucosidase inhibition of 5-aryl-2-(6'-nitrobenzofuran-2'-yl)-1,3,4-oxadiazoles. Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Saad SM; Khan KM; Nasir A Bioorg Chem; 2016 Jun; 66():117-23. PubMed ID: 27149363 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs. Javid MT; Rahim F; Taha M; Rehman HU; Nawaz M; Wadood A; Imran S; Uddin I; Mosaddik A; Khan KM Bioorg Chem; 2018 Aug; 78():201-209. PubMed ID: 29597114 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases. Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors. Wang G; Wang J; He D; Li X; Li J; Peng Z Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827 [TBL] [Abstract][Full Text] [Related]
18. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition. Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079 [TBL] [Abstract][Full Text] [Related]
19. Exploring fluorine-substituted piperidines as potential therapeutics for diabetes mellitus and Alzheimer's diseases. Mughal EU; Hawsawi MB; Naeem N; Hassan A; Alluhaibi MS; Ali Shah SW; Nazir Y; Sadiq A; Alrafai HA; Ahmed SA Eur J Med Chem; 2024 Jul; 273():116523. PubMed ID: 38795518 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro evaluation and molecular docking studies of novel amide linked triazolyl glycoconjugates as new inhibitors of α-glucosidase. Gupta SJ; Dutta S; Gajbhiye RL; Jaisankar P; Sen AK Bioorg Chem; 2017 Jun; 72():11-20. PubMed ID: 28346871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]